Expression and clinical significance of thrombospondin-1 and plasminogen activator inhibitor-1 in patients with mesangial proliferative glomerulonephritis.
Pan C, Zhou C, Shan A, Chen N.
Ann Palliat Med. 2020 Sep;9(5):3187-3193. doi: 10.21037/apm-20-1291. Epub 2020 Aug 31.
Mesangial proliferative glomerulonephritis with or without IgA deposits: the morphological characters in psoriasis vulgaris.
Jiao Y, Xu H, Li H, Li X.
Nephron Clin Pract. 2008;108(3):c221-5. doi: 10.1159/000119716. Epub 2008 Mar 7.
The role of the mesangial cell in proliferative glomerulonephritis.
Davison AM, Thomson D, MacDonald MK, Uttley WS, Robson JS.
J Clin Pathol. 1973 Mar;26(3):198-208. doi: 10.1136/jcp.26.3.198.
Pathological regression by angiotensin II type 1 receptor blockade in patients with mesangial proliferative glomerulonephritis.
Ohtake T, Oka M, Maesato K, Mano T, Ikee R, Moriya H, Kobayashi S.
Hypertens Res. 2008 Mar;31(3):387-94. doi: 10.1291/hypres.31.387.
Mesangial proliferative glomerulonephritis. Natural history and effects of dextran sulfate.
Dohi K, Nakamoto Y, Ishikawa H.
Jpn J Med. 1987 Feb;26(1):50-7. doi: 10.2169/internalmedicine1962.26.50.
Mesangial proliferative glomerulonephritis associated with progressive amyloid deposition in hamsters experimentally infected with Leishmania donovani.
Oliveira AV, Roque-Barreira MC, Sartori A, Campos-Neto A, Rossi MA.
Am J Pathol. 1985 Aug;120(2):256-62.
Clinicopathologic features, outcome, and therapeutic interventions in four children with isolated C3 mesangial proliferative glomerulonephritis.
Yagi K, Yanagida H, Sugimoto K, Kuwajima H, Tabata N, Morita K, Okada M, Takemura T.
Pediatr Nephrol. 2005 Sep;20(9):1273-8. doi: 10.1007/s00467-005-1919-4. Epub 2005 Jun 10.
Identification of plasma miR-106a-5p and miR-30a-5p as potential biomarkers for mesangial proliferative glomerulonephritis.
Wang L, Lin J, Yu T, Zuo Q, Shen B, Zhang H, Liu B, Cai D, Mao H, Zhao H, Zou Q, Xiao B.
Clin Biochem. 2020 Oct;84:79-86. doi: 10.1016/j.clinbiochem.2020.07.001. Epub 2020 Jul 13.
Multicentric Castleman's disease with renal amyloidosis and mesangial proliferative glomerulonephritis: a case report.
Tan Z, Wang L, Wang C, Gao L, Yang Y.
Int J Clin Exp Med. 2015 Feb 15;8(2):2966-73. eCollection 2015.
Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits in a young woman: A case report.
Xu ZG, Li WL, Wang X, Zhang SY, Zhang YW, Wei X, Li CD, Zeng P, Luan SD.
World J Clin Cases. 2021 Apr 6;9(10):2357-2366. doi: 10.12998/wjcc.v9.i10.2357.
